Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China
· Delayed Price · Currency is CNY 19.49
+0.53 (2.80%)
Apr 29, 2026, 3:06 PM CST
Dian Diagnostics Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 11,586 | 9,686 | 6,941 | 14,881 | 15,754 | 20,829 | Upgrade
|
| Market Cap Growth | 19.30% | 39.54% | -53.35% | -5.54% | -24.37% | -2.07% | Upgrade
|
| Enterprise Value | 13,851 | 12,955 | 11,653 | 19,072 | 20,099 | 24,657 | Upgrade
|
| Last Close Price | 18.96 | 15.85 | 11.16 | 21.73 | 22.77 | 30.28 | Upgrade
|
| PE Ratio | 262.97 | 219.87 | - | 48.40 | 10.99 | 17.91 | Upgrade
|
| Forward PE | 26.68 | 22.81 | 11.41 | 11.88 | 8.08 | 15.56 | Upgrade
|
| PS Ratio | 1.15 | 0.96 | 0.57 | 1.11 | 0.78 | 1.59 | Upgrade
|
| PB Ratio | 1.35 | 1.13 | 0.79 | 1.50 | 1.66 | 2.79 | Upgrade
|
| P/TBV Ratio | 1.93 | 1.61 | 1.15 | 2.24 | 2.40 | 4.61 | Upgrade
|
| P/FCF Ratio | 6.65 | 5.56 | 8.22 | 12.20 | 22.78 | 28.60 | Upgrade
|
| P/OCF Ratio | 5.71 | 4.78 | 5.75 | 7.75 | 9.61 | 15.80 | Upgrade
|
| PEG Ratio | - | 0.38 | 0.38 | 0.38 | 0.38 | 0.71 | Upgrade
|
| EV/Sales Ratio | 1.37 | 1.28 | 0.96 | 1.42 | 0.99 | 1.89 | Upgrade
|
| EV/EBITDA Ratio | 12.47 | 12.45 | 12.55 | 13.00 | 4.73 | 9.99 | Upgrade
|
| EV/EBIT Ratio | 18.68 | 17.47 | 21.33 | 18.82 | 5.50 | 11.59 | Upgrade
|
| EV/FCF Ratio | 7.95 | 7.43 | 13.80 | 15.64 | 29.06 | 33.85 | Upgrade
|
| Debt / Equity Ratio | 0.31 | 0.31 | 0.41 | 0.42 | 0.63 | 0.58 | Upgrade
|
| Debt / EBITDA Ratio | 2.39 | 2.39 | 3.13 | 2.46 | 1.34 | 1.66 | Upgrade
|
| Debt / FCF Ratio | 1.52 | 1.52 | 4.23 | 3.44 | 8.66 | 5.99 | Upgrade
|
| Net Debt / Equity Ratio | 0.01 | 0.01 | 0.16 | 0.08 | 0.14 | 0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.10 | 0.10 | 1.46 | 0.55 | 0.32 | 0.71 | Upgrade
|
| Net Debt / FCF Ratio | 0.06 | 0.06 | 1.61 | 0.66 | 1.94 | 2.40 | Upgrade
|
| Asset Turnover | 0.67 | 0.67 | 0.72 | 0.69 | 1.11 | 0.94 | Upgrade
|
| Inventory Turnover | 4.54 | 4.54 | 5.61 | 6.29 | 9.26 | 6.60 | Upgrade
|
| Quick Ratio | 2.17 | 2.17 | 2.08 | 2.41 | 1.93 | 1.38 | Upgrade
|
| Current Ratio | 2.66 | 2.66 | 2.54 | 2.82 | 2.17 | 1.63 | Upgrade
|
| Return on Equity (ROE) | 1.68% | 1.68% | -1.81% | 5.99% | 21.94% | 21.97% | Upgrade
|
| Return on Assets (ROA) | 3.07% | 3.07% | 2.02% | 3.25% | 12.47% | 9.50% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.57% | 4.48% | 5.25% | 6.85% | 26.69% | 21.55% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 7.20% | 4.90% | 7.80% | 27.50% | 23.80% | Upgrade
|
| Earnings Yield | 0.38% | 0.46% | -5.15% | 2.07% | 9.10% | 5.58% | Upgrade
|
| FCF Yield | 15.04% | 18.00% | 12.16% | 8.20% | 4.39% | 3.50% | Upgrade
|
| Dividend Yield | 4.75% | - | 8.07% | 0.28% | 0.88% | 0.45% | Upgrade
|
| Payout Ratio | 580.66% | 580.66% | - | 97.78% | 20.70% | 22.88% | Upgrade
|
| Buyback Yield / Dilution | 0.98% | 0.98% | 1.30% | -0.18% | 0.02% | -0.43% | Upgrade
|
| Total Shareholder Return | 5.73% | 0.98% | 9.37% | 0.09% | 0.90% | 0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.